Switch to a bicarbonate-based Impella CP™ purge solution in a patient with haemothorax: a case report.

Here, we present the first case report of the switch to BBPS in an Impella CP™ supported patient with major bleeding since the FDA approval in April 2022. The switch to BBSP in addition with the administration of platelets and protamine resulted in cessation of the bleeding in this case.